Govt Job: For Pharmacist in ECHS Polyclinics

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high-cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance (Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme (Management Information System) (AFGIS (MIS)) schemes.

These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees.

ECHS invites applications to engage the following medical and paramedical staff on a contractual basis in ECHS Polyclinics at Barrackpore, Krishnanagar, and Behrampur for a period of one year for ESM and two months for civil candidates.

Post : Pharmacist

No of Posts: 01 (Krishnanagar-01)

Basic Qualification :
B.Pharmacy from a recognized Institute OR approved Diploma in Pharmacy from Recongnized by the Pharmacy Council of India and registered as Pharmacist under the Pharmacy Act 1948

Work Exp: Minimum 3 years of experience
Salary: Rs 28,100/-

Last Date of Receipt of Application as per Format Given on our Website. Application as per requisite format along with self-attested photocopies of testimonials in support of educational qualifications and work experience will be submitted to OIC, ECHS Cell. Stn HQ Barrackpore, Kolkata, Pin-700120 by August 6th, 2022.

Any application received after August 6th, 2022, will not be accepted.

Interview Date, Timing & Venue
Interview to be held in the 3rd or 4th week of August 2022. Candidates must reach Stn HQ Barrackpore at 0830 hrs on a concerning day for the interview to be held w.e.f. 0900 hrs to 1400 hrs.

Candidates must bring all the original certificates/mark sheets/degree of 10th/ Matric, 10+2 & Graduation/post graduation/diploma/course, work experience and discharge book, PPO, service records, and 3.5 x 4.5 cm PP size color photographs at the lime of interview.

No TA/DA is admissible. Only candidates meeting the Qualitative Requirement should apply.

Related Posts

  • Pharma
  • July 3, 2025
  • 95 views
Cipla in talks to add new customers for its China factory, executive says

SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to…

  • Pharma
  • July 3, 2025
  • 86 views
No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cipla in talks to add new customers for its China factory, executive says

Cipla in talks to add new customers for its China factory, executive says

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs